Donation will assist in the development of antisense oligonucleotide (ASO) medicines to nano-rare disease patients worldwide Third consecutive annual donation, now totaling around $1.4 million Cytiva has donated approximately $700,000… Read More
The Canadian Alliance for Skills and Training in Life Sciences (CASTL) partners with the School of Biomedical Engineering (SBME) and the Department of Chemical and Biological Engineering (CHBE) at the… Read More
An mRNA therapeutic’s path to market-readiness is filled with challenges, particularly when it comes to efficiency and yield. Fitting a new therapy like mRNA into a process tailored for well-established… Read More
Collaboration to leverage AbbVie’s psychiatry expertise and Gilgamesh’s innovative research platform to develop next-generation neuroplastogens for the treatment of psychiatric disorders NORTH CHICAGO, IL & NY – AbbVie (NYSE: ABBV) and Gilgamesh… Read More
VANCOUVER, BC – WAT Medical, a leader in innovative healthcare solutions, announces the development of ObeEnd, the world’s first weight management wristband backed by clinical evidence showcasing its efficacy in… Read More
